美国 · 平台与数据 · Morningstar
Newleos Announces $15.5 Million NIH Grant and Receipt of FDA Fast Track Designation for NTX-2001 to Treat Substance Use Disorders | Morningstar
Newleos also announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to NTX-2001 for the treatment of AUD. The FDA’s Fast Track process…
在 Morningstar 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.morningstar.com)




